Morgan Stanley analyst Tejas Savant maintains $Hologic (HOLX.US)$ with a hold rating, and maintains the target price at $84.
According to TipRanks data, the analyst has a success rate of 37.3% and a total average return of -6.1% over the past year.
Furthermore, according to the comprehensive report, the opinions of $Hologic (HOLX.US)$'s main analysts recently are as follows:
Following Hologic's Q4 results and initial FY25 guidance, it is argued that the company's outlook seems attainable, with a low 30% operating margin target that appears to be realistic. Additionally, the focus on mergers, acquisitions, and share buybacks is still seen as favorable. Hologic's management has also emphasized their expansion efforts into new international markets, despite these typically yielding lower margins compared to the U.S. business.
The company reported a mixed fiscal Q4. The stock's discounted valuation, along with the strength in the core business and the absence of GLP-1 exposure, are factors that continue to support a positive perspective on the shares.
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
摩根士丹利分析师Tejas Savant维持$豪洛捷 (HOLX.US)$持有评级，维持目标价84美元。
根据TipRanks数据显示，该分析师近一年总胜率为37.3%，总平均回报率为-6.1%。
此外，综合报道，$豪洛捷 (HOLX.US)$近期主要分析师观点如下：
在豪洛捷的第四季度业绩和2025财年初步指引后，有人认为公司的前景似乎是可以实现的，低于30%的营业利润率目标看起来是切实可行的。此外，专注于兼并、收购和股票回购仍然被视为有利的。豪洛捷的管理层还强调他们的扩张努力进入新的国际市场，尽管这些市场通常与美国的业务相比产生较低的利润率。
该公司报告了一个综合的财政第四季度。该股票的折价估值，以及核心业务的实力和缺乏GLP-1暴露，是继续支持对股票持积极态度的因素。
提示:
TipRanks为独立第三方，提供金融分析师的分析数据，并计算分析师推荐的平均回报率和胜率。提供的信息并非投资建议，仅供参考。本文不对评级数据和报告的完整性与准确性做出认可、声明或保证。
TipRanks提供每位分析师的星级，分析师星级代表分析师所有推荐的过往表现，通过分析师的总胜率和平均回报率综合计算得出，星星越多，则该分析师过往表现越优异，最高为5颗星。
分析师总胜率为近一年分析师的评级成功次数占总评级次数的比率。评级的成功与否，取决于TipRanks的虚拟投资组合是否从该股票中产生正回报。
总平均回报率为基于分析师的初始评级创建虚拟投资组合，并根据评级变化对组合进行调整，在近一年中该投资组合所获得的回报率。
